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MiR-192-5pThe SCN5A gene encodes cardiac sodium channel Nav1.5 and causes lethal ventricular arrhythmias/sudden death
and atrial ﬁbrillation (AF) whenmutated. MicroRNAs (miRNAs) are important post-transcriptional regulators of
gene expression, and involved in the pathogenesis of many diseases. However, little is known about the regula-
tion of SCN5A by miRNAs. Here we reveal a novel post-transcriptional regulatory mechanism for expression and
function of SCN5A/Nav1.5 via miR-192-5p. Bioinformatic analysis revealed that the 3′-UTR of human and rhesus
SCN5A, but not elephant, pig, rabbit, mouse, and rat SCN5A, contained a target binding site for miR-192-5p and
dual luciferase reporter assays showed that the site was critical for down-regulation of human SCN5A. With
Western blot assays and electrophysiological studies,wedemonstrated thatmiR-192-5p signiﬁcantly reduced ex-
pression of SCN5A and Nav1.5 as well as peak sodium current density INa generated byNav1.5. Notably, in situ hy-
bridization, immunohistochemistry and real-time qPCR analyses showed thatmiR-192-5p was up-regulated in
tissue samples from AF patients, which was associated with down-regulation of SCN5A/Nav1.5. These results
demonstrate an important post-transcriptional role of miR-192-5p in post-transcriptional regulation of Nav1.5,
reveal a novel role of miR-192-5p in cardiac physiology and disease, and provide a new target for novel
miRNA-based antiarrhythmic therapy for diseases with reduced INa.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Nav1.5 is the primary voltage-gated sodium channel in the heart and
responsible for the fast depolarization and generation of the cardiac ac-
tion potential (AP) and conduction of the cardiac AP [1]. It is encoded by
the SCN5A gene on chromosome 3p21 [1]. SCN5A is one of the ﬁrst two
genes identiﬁed for long QT syndrome (LQTS), an inherited cardiac ar-
rhythmia [2,3,4,5]. LQTS mutations in SCN5A act by a gain-of-function
mechanism, mostly by generating late persistent sodium currents [6].
On the other hand, loss-of-function mutations were later identiﬁed by, The First Afﬁliated Hospital of
r Human Genome Research,
PR China.
rg (Q.K. Wang),
eliability and freedom frombiasus and others in SCN5A in patients with Brugada syndrome (BrS), cardi-
ac conduction defects, sudden infant death, sick sinus syndrome, dilated
cardiomyopathy and atrial ﬁbrillation (AF) [7,8,9,10]. Moreover, INa
density was reduced in AF patients [11] and a dog model for AF [12],
but the underlying molecular mechanism is unknown. Reduced Nav1.5
expression and INa were also detected in the atria in a mouse model
for catecholamine-induced VT with the RyR2-P2328S gain-of-function
mutation [13]. Similarly, reduced INa density has also been associated
with more common cardiovascular diseases such as heart failure [14,
15,16] and myocardial ischemia [17], but the underlying molecular
mechanism is unknown either.
Post-transcriptional regulation by microRNAs (miRNAs) may be an
attractive, putative mechanism for the observed reduction of INa in AF,
heart failure, and myocardial ischemia [18]. MiRNAs are small, non-
coding RNAs (about 22 nucleotide long) that regulate gene expression
through translational repression or mRNA degradation, typically by
binding to their targeted sites located in the 3′ untranslated regions
(3′-UTRs) of mRNAs [19,20]. For example, miR-1, miR-133, miR590,
miR-208a and miR-328 have been found to be signiﬁcantly associated
2025Y. Zhao et al. / Biochimica et Biophysica Acta 1852 (2015) 2024–2034with AF and heart failure [21,22]. Many miRNAs that regulate the ex-
pression of cardiac ion channels have been reported. For example,
miR-1 regulates KCNJ2, CACNA1C, and GJA1; miR-133 regulates ERG;
miR-328 regulates CACNA1C and CACNB1; miR-212 regulates KCNJ2;
miR-208a regulates GJA5 [23]. In this study, we found that cardiac sodi-
um channel gene SCN5Awas regulated bymiR-192-5p.MiR-192-5pwas
ﬁrst identiﬁed by Lagos Quintana et al. [24] and later by Lim et al. [25].
MiR-192-5pwas shown to be highly expressed in kidney and hepatocel-
lular carcinoma tissue samples [26,27], but its expression in cardiac tis-
sues was not reported. In this study, we reveal thatmiR-192-5p binds to
the 3′-UTR of human SCN5A to negatively regulate the expression of
Nav1.5 and reduce INa density. We further show that the expression of
miR-192-5p is signiﬁcantly reduced in human AF tissues compared
with normal tissue samples and associated with down-regulation of
SCN5A/Nav1.5.2. Methods
2.1. Study subjects
This study was approved by the appropriate local institutional re-
view boards on human subject research at the First Afﬁliated Hospital
of Xiamen University and Huazhong University of Science and Technol-
ogy and conformed to the guidelines set forth by the Declaration of
Helsinki. Written informed consent was obtained from the participants.
We studied left atrial appendage tissue samples from AF patients with
rheumatic valve disease and control subjects with rheumatic valve dis-
ease alone for the expression levels of miR-192-5p and SCN5A/Nav1.5.
The demographic and clinical characteristics of study subjects are
shown in Table 1.2.2. Mutational analysis by sequencing analysis
Extraction of human genomic DNA from blood samples was as de-
scribed previously by us [28]. All exons, intron–exon boundaries and
5′ and 3′ UTRs of SCN5A were ampliﬁed by polymerase chain reactions
(PCR) using primers published before [29]. The PCR products were
puriﬁed by agarose gel electrophoresis, followed by direct sequencing
using the BigDye® Terminator v3.1 Cycle Sequencing Kit (Life
Technologies).Table 1
Clinical and demographic characteristics of study subjects.
ID Gender Age Height
(cm)
Weight
(kg)
BMI
(kg/m2)
Systolic
(mm Hg)
O2 F 49 158 47 0.30 110
7 F 27 163 50 0.31 122
5 F 40 160 56 0.35 130
Y2 F 60 – – – 105
3 F 43 163 57 0.35 112
8 F 61 161 53 0.33 130
A F 51 156 53 0.34 104
B F 43 – – – –
M M 62 – – – –
L F 48 145 40 0.28 100
G F 35 160 54 0.34 102
F M 73 – – – 123
qPCR, real-time quantitative RT-PCR analysis; ISH, in situ hybridization; Immunohis, immunoh2.3. Bioinformatic analysis
The sequences at SNP rs41310757 and in its ﬂanking regions were
analyzed for potential binding sites for miRNAs by bioinformatic analy-
ses.Weused several onlinemiRNAbinding site prediction software pro-
grams with different algorithms, including TargetScan (http://www.
targetscan.org/), RNA Hybrid (http://bibiserv.tenchfak.uni-bielefeld.
de/rnahybird), miRWalk (http://www.umm.uni-heidelberg.de/apps/
zmf/mirwalk/), DIANA-microT v3.0 (http://diana.cslab.ece.ntua.gr/
microT/), and microRNA.org (http://www.microrna.org/microrna/
getGeneForm.do).2.4. Cell lines, plasmids and miRNAs
HCT116 cells (human colorectal carcinoma cell), SW620 cells
(human colorectal adenocarcinoma cell) and HEK293 cells (human em-
bryonic kidney cell)were purchased fromATCC (American TypeCulture
Collection, Rockville, MD, USA). Cells were cultured in Dulbecco's Mod-
iﬁed Eagle's medium (DMEM) supplemented with 10% fetal bovine
serum (FBS, Gibco Life Technologies, Gaithersburg, MD, USA) in a hu-
midiﬁed incubator with 5% CO2 at 37 °C.
We ampliﬁed a region of the 3′-UTR of SCN5A that contains the pre-
dicted miR-192-5p target binding site using human genomic DNA. The
PCR product included two restriction sites, Sac I at the left end and
Hind III at the right end. The PCR product was cut with the two enzymes
and sub-cloned into themultiple cloning site of the pMIR-REPORT lucif-
erase vector (Applied Biosystems, Foster City, CA, USA) (Fig. 1A). Two
reporter genes were created. Reporter gene pMIR-REPORT-SCN5A-3′
UTR-T contains the wild type binding sequence formiR-192-5p, where-
as pMIR-REPORT-SCN5A-3′UTR-C contains a variant, a T to C substitu-
tion (single nucleotide polymorphism or SNP rs41310757), at the miR-
192-5p binding sequence. The sequences of primers are 5′ACTCTGGC
CCCCTATTGTCT3′ for the forward primer and 5′CACCCTTGTGTCCTTT
GGTT3′ for the reverse primer.
The putative target binding site of miR-192-5p at the 3′-UTR of
human SCN5A, AGGTCAT, was deleted from pMIR-REPORT-SCN5A-3′
UTR-T by overlapping PCR-based mutagenesis as previously described
[30]. This generated a mutant reporter, pMIR-REPORT-SCN5A-3′UTR-
T-Mut.
The pHL3 expression plasmid for SCN5A was described previously
[31,32,33]. The whole 3′-UTR of SCN5A with the miR-192-5p bindingDiastolic
(mm Hg)
AF Other cardiovascular disease Test
72 No Mitral stenosis and incompetence qPCR
71 No Mitral stenosis and incompetence qPCR
60 No Aortic valve stenosis and incompetence qPCR
70 Yes Heart valve disease qPCR
73 Yes Heart valve disease qPCR
82 Yes Heart valve disease qPCR
88 Yes Heart valve disease ISH
Immunohis
– Yes Heart valve disease ISH
Immunohis
– Yes Congenital heart disease,
ventricular septal defect
ISH
Immunohis
65 No Heart valve disease ISH
Immunohis
74 No Heart valve disease ISH
Immunohis
60 No Heart valve disease ISH
Immunohis
istochemical analysis.
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China) and used for Western blot and electrophysiological studies.
MiR-192-5pmimics and negative control miRNA mimics were pur-
chased from Guangzhou RioboBio (Guangzhou, Guangdong, China).
The miR-192-5pmimics were chemically synthesized double-stranded
RNA molecules with the sequence identical to the mature miR-192-5p
sequence.When themimicswere transfected into cells, it would be rec-
ognized and processed by Argonaute (AGO) and RNA-induced silencing
complex (RISC) into single-stranded, functionalmiR-192-5p. The nega-
tive control miRNA mimics were miR-mimics with sequences that do
not bind any mRNA in humans.2.5. Dual luciferase reporter assays
HCT116 cells were cultured in 24-well plates for 24 h and
transfected with 200 ng of either pMIR-REPORT-SCN5A-3′UTR-T or
pMIR-REPORT-SCN5A-3′UTR-C and 100 nM of miR-192-5p mimics or
negative control NC-miRNAmimics, alongwith 20 ngof thepRL-TK vec-
tor containing the Renilla luciferase gene (Promega, Madison,WI, USA).
The transfection was carried out using 2 μl of lipofectamine 2000 and
500 μl of Opti-MEM reduced serum medium according to the
manufacturer's the protocol (Gibco Life Technologies, Gaithersburg,
MD, USA). Cells were harvested 48 h after transfection and lysed using
1× passive lysis buffer (Promega, Madison, WI, USA). Luciferase assays
were performed as described by us previously [34] and using the
Dual-Glo luciferase assay kit (Gibco Life Technologies, Gaithersburg,
MD, USA). The ratio of ﬁreﬂy over Renilla luciferase activities was calcu-
lated and considered as theﬁnal luciferase activity value. Each assaywas
performed in triplicate and repeated at least three times.2.6. Quantitative real time RT-PCR analysis
To examine the effect of miR-192-5p on the expression of SCN5A
mRNA, we searched literature for a cell line with expression of SCN5A
and found that SW620 cells expressed a high level of endogenous
Nav1.5 protein [35]. Therefore, SW620 cells were cultured in 24-well
plates for 24 h and transfected with 100 nM of miR-192-5pmimics or
NC-miRNA mimics using lipofectamine 2000 and Opti-MEM reduced
serum medium according to the manufacturer's the protocol (Gibco
Life Technologies, Gaithersburg, MD, USA). Cells were collected 48 h
after transfection and lysed using RNAiso plus (TaKaRa, Dalian, China).
Total RNA was isolated from cells using the Trizol reagent (TaKaRa,
Dalian, China) and converted into cDNA by reverse transcription using
oligo(dT)15 with the First-Strand cDNA Synthesis kit (Toyobo, Japan).
Total RNA samples were also isolated from left atrial appendage
samples from three AF patients (Y2, 3, 8) and three non-AF control pa-
tients (O2, 7, 5) (Table 1) using the Trizol reagent (TaKaRa, Dalian,
China). Total RNA was converted into cDNA as described above.
Real time qPCR analysis was carried out using the FastStart Universal
SYBR Green Master kit (Roche Applied Science, Mannheim, Germany)
in a 10 μl reaction volume on an ABI 7900 Genome Analyzer System.
The reaction system contained 2 μl of cDNA template, 5 μl of SYBR
green mix (including ROX), 200 nM of forward primer and 200 nM of
reverse primer (a total volume of 10 μl). Human GAPDH was used as
an internal standard. The primers for RT-PCR analyses were listed in
Table 2. The PCR products were veriﬁed by melting curve analysis andFig. 1.MiR-192-5p down-regulates expression of the SCN5A geneby targeting the 3′-UTR. A. Bioi
A diagram showing luciferase reporter constructs containing themiR-192-5p targeting sequence
predictedmiR-192-5p target sequences are indicated. The evolutionary conservation of themiR
the bottom. B. The sequence of the 3′-UTR fragment of human SCN5A, which contains the target
tor. Forward and reverse primers used for PCR-ampliﬁcation of the 3′-UTR fragment of SCN5A a
compared with negative control mimics (NC-control) transfected into HCT116 cells. Three luci
taining the C allele of rs41310757, the reporterwith the T allele, and the reporterwith themiR-1
ﬁreﬂy/Renilla activities and normalized to the negative control mimic group. Results were obt
shown as means ± SD.the results were analyzed using the 2−ΔΔCt method as described [36].
Each assaywas performed in triplicate and repeated at least three times.
Expression of miR-192-5p was carried out for left atrial appendage
samples from three AF patients and three non-AF controls (Table 1)
using the stem-loop real-time PCR as described previously [37]. Total
RNA was isolated as described above. Bulge-loop™ miRNA qRT-PCR
Primer Sets (one RT primer and a pair of qPCR primers for each set)
speciﬁc for miR-192-5p were purchased from RiboBio (Guangzhou,
Guangdong, China). MiRNA bulge-loop was reverse transcribed with
the First-Strand cDNA Synthesis kit (Invitrogen, Carlsbad, CA, USA)
using the speciﬁc miR-192-5p RT primer. Real time qPCR analysis was
carried out as described for SCN5A above except that the reaction vol-
ume was 20 μl and the internal control was U6 small RNA.
2.7. Electrophysiological studies
HEK293 cells are the most commonly used cells for electrophysio-
logical studies of cardiac sodium channels. HEK293 cells were cultured
at 37 °C under 5% CO2 in high glucose DMEM media supplemented
with 10% FBS (Invitrogen). When cell culture was 70–80% conﬂuent in
3.5-cm plates, transfection was carried out with 2 μg of pcDNA3-
SCN5A-whole 3′UTR and 200 ng of pEGFP-N1 withmiR-192-5pmimics
or negative control NC-miRNA mimics using lipofectamine 2000 and
Opti-MEM reduced serum medium. Cells were cultured for 48 h and
EGFP-positive cells were selected for patch-clamp recordings. We re-
corded sodium current at room temperature using a Multiclamp 700B
ampliﬁer (Axon Instruments, Sunnyvale, CA). The patch pipette (tip re-
sistance was 2–3MΩ) was ﬁlled with following solutions as described
previously [3,38,39]: 20 mM NaCl, 130 mM CsCl, 10 mM HEPES, and
10mMEGTA, pH 7.2 (adjustedwith CsOH). The components of bath so-
lution was 70 mM NaCl, 80 mM CsCl, 5.4 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, 10 mM HEPES, and 10 mM glucose, pH 7.3 (adjusted with
CsOH). All chemicals were purchased from Sigma (Madison, WI, USA).
The junction potential, capacitance and series resistance were automat-
ically compensated in the whole cell conﬁguration. The holding poten-
tial was maintained at −120 mV, and the voltage clamp protocols
were as described previously. The sodium currents were ﬁltered at
5 kHz, sampled at 50 kHz, and stored on a desktop computer equipped
with an AD converter (Digidata 1440A, Molecular Devices). All current
measurements were normalized using the cell capacitance. The Clamp
ﬁt 10.2 (Axon Instruments), Excel (Microsoft), and Origin 85 (Microcal
Software) were used for data acquisition and analysis.
2.8. Western blot analysis
Cells were cultured and transfected as described above. Transfected
cells were collected and incubated in ice-cold TNEN lysis buffer (in
mmol/l: 50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 2.0 mM EDTA, 1.0%
Nonidet P-40) with 1 mini tab of EDTA-free protease inhibitors
(Roche) and 1 mmol/l PMSF (phenylmethylsulfonyl ﬂuoride) for
30 min at 4 °C. The insoluble fraction was pelleted by centrifugation at
12,000 ×g for 15 min at 4 °C. 100 μl of supernatant was mixed with
20 μl of 6× Laemmli buffer (0.3 mol/l Tris–HCl, 6% SDS, 60% glycerol,
120 mmol/l dithiothreitol (DDT) and proprietary pink tracking dye),
and heated at 37 °C for 10 min. Then, 20 μl of samples was subjected
to SDS-PAGE. After electrophoresis, proteins were transferred onto a
0.45 μm polyvinylidene ﬂuoride (PVDF) membrane (Millipore). Thenformatic analysis identiﬁed a potential binding site formiR-192-5p at the 3′-UTR of SCN5A.
swith theC allele or T allele of rs41310757 is shown. ThemiR-192-5p “seed region” and the
-192-5p binding sequences at the 3′-UTR of SCN5A is shown for several different species at
binding sequence ofmiR-192-5p andwas subcloned into the pMIR-REPORT luciferase vec-
re shown. C. Effects ofmiR-192-5pmimics on the pMIR-SCN5A-3′UTR luciferase reporters
ferase reporters were analyzed, including the pMIR-SCN5A-3′UTR luciferase reporter con-
92-5p target sequence (aggtcat) deleted. Luciferase activitieswere calculated as the ratio of
ained from three independent experiments. The data was normalized to NC-miR. Data is
2027Y. Zhao et al. / Biochimica et Biophysica Acta 1852 (2015) 2024–2034membrane was probed with an anti-Nav1.5 rabbit polyclonal antibody
(Alomone, ASC-005), followed by incubation with a HRP-conjugated
secondary goat anti-rabbit antibody (Millipore). The protein signalwas visualized by a Super SignalWest Pico Chemiluminescent substrate
according to the manufacturer's instructions (Pierce Chemical Co.,
Rockford, Illinois, USA). Human GAPDH was used as loading control.
Table 2
The primer sequences for RT-PCR analysis of SCN5A and control GAPDH.
Gene Forward Reverse
SCN5A CCAGATCTCTATGGCAATCCA GAATCTTCACAGCCGCTCTC
GAPDH AGTCAGCCGCATCTTCTT GCCCAATACGACCAAATCC
2028 Y. Zhao et al. / Biochimica et Biophysica Acta 1852 (2015) 2024–2034Each assaywas performed in triplicate and repeated at least three times.
2.9. In situ hybridization analysis (ISH)
ISH for miR-192-5p was carried out using a Dig-labeledmiR-192-5p
antisense probe. The sequence of the probe was 5′-GGCTGTCAATTCAT
AGGTCAG-3′. Human left atrial appendage samples from three AF pa-
tients (A, B, M) and three non-AF controls (L, G, F) (Table 1) were
ﬁxed in 4% paraformaldehyde (PFA) and parafﬁn-embedded. Serial sec-
tions of 5 μm were cut and hybridized in 100 ml hybridization buffer
with 50 pM of denatured Dig-labeled probe at 42 °C overnight. The sec-
tions were then washed with 1× SSPE buffer (8.765 g NaCl, 1.38 g
NaH2PO4 and 0.37 g EDTA–Na2·2H2O dissolved with 500 ml DEPC
H2O, pH 7.4) and incubated with an anti-DIG-AP antibody in 1×
blocking buffer (2% sheep serum and 0.1% Triton X-100 dissolved with
100 mM Tris–HCl and 150 mM NaCl, pH 7.5) for 2 h. The sections
were then stained with 45 μg Nitroblue tetrazolium (NBT) in 10 ml
TNM-50 (50 ml Tris, pH 7.5, 10 ml 5 M NaCl and 25 ml 1 M MgCl2 dis-
solved with 500 ml DEPC H2O, pH 9.0) for 12 h and imaged under a mi-
croscope (LEICA). The ﬂorescent optical density for miR-192-5p was
quantiﬁed using a computer image analysis program (Image J) and
analyzed for differences between the AF group and the control group
by Student's t-test.
2.10. Immunohistochemical analysis
Immunohistochemistry was performed for Nav1.5 with human left
atrial appendage samples from three AF patients (A, B, M) and three
non-AF controls (L, G, F) (Table 1) as described [37]. A polyclonal anti-
Nav1.5 antibody from Sigma-Aldrich (St. Louis, MO, USA) was used for
immunohistochemistry staining.
2.11. Statistical analysis
Experimental data from at least three independent experimentswas
presented asmeans± standard deviation (S.D.). Statistical analysis was
performedwith Student's t-test using SPSS version 17.0 software (SPSS,
Chicago, IL, USA). A P value of 0.05 or less was considered to be
signiﬁcant.
For analysis of the data from real-time RT-PCR analysis, we calculat-
ed the means for RQ values from the 3 wells and then compare the
means from three independent experiments between two different
groups with Student's t-test. For Western blot analysis, the images
from three independent experiments were scanned with Quantity
One 4.6.8 (Basic) (Bio-Rad, Hercules, California, USA) and quantiﬁed.
The density of the Nav1.5 protein band for the miR-192-5p treatment
group was calibrated to that for the control sample (NC-miR). The
means from three independent experiments were compared between
two different groups with Student's t-test.
3. Results
3.1. Identiﬁcation of miR-192-5p as a potential posttranscriptional regulator
of cardiac sodium channel gene SCN5A
During mutational screening of the SCN5A gene in a panel of 45 BrS
patients, we identiﬁed a T to C variant in the 3′-UTR of SCN5A
(754 bps from the stop codon), which appeared to be a common poly-
morphism (SNP rs41310757). The minor allele frequency (MAF) of thers41310757 variant was 37.30% in the BrS group, which was higher
than that in a group of 100 Chinese Han controls (31.2%) (P = 0.04).
TheMAF of the rs41310757 variantwas similar to that in the NCBI data-
base for the East Asian population (http://www.ncbi.nlm.nih.gov/
projects/SNP/snp_ref.cgi?rs=41310757) (32.50%). Bioinformatic analy-
sis of the sequences ﬂanking SNP rs41310757 revealed a potential bind-
ing site formiR-192-5p (Fig. 1A). ThemiR-192-5p binding site on SCN5A
shows Watson–Crick matches to the seed region of miR-192-5p
(Fig. 1A). The mature sequence ofmiR-192-5p and potential binding re-
gions are shown in Fig. 1A. Interestingly, the putativemiR-192-5p target
binding sequences at the 3′UTR of human SCN5A are not evolutionarily
conserved. High conservation was observed only with rhesus and dogs,
but not with the pig, elephant, rabbit, mouse, rat, chicken, zebraﬁsh and
Xenopus tropicalis (Fig. 1A). The data supports the hypothesis that
human SCN5Amay be regulated by miR-192-5p.
3.2. Analysis of regulation of miR-192-5p on the expression of SCN5A using
pMIR-REPORT luciferase reporters
Based on the data from the bioinformatic analysis described above,
we hypothesized that miR-192-5p could bind to the 3′-UTR of SCN5A
and regulate the expression of SCN5A. To test the hypothesis, we cloned
a 194 bp region that contains the predictedmiR-192-5p binding site and
ﬂanking sequences at the 3′-UTR of SCN5A into the pMIR-REPORT lucif-
erase vector, resulting in a reporter gene pMIR-SCN5A-3′UTR-Twith the
T allele of SNP rs41310757 and pMIR-SCN5A-3′UTR-C with the C allele
(Fig. 1A, B).
Each reporter was co-transfected withmiR-192-5pmimics and neg-
ative NC-control mimics into cells and luciferase assays were carried
out. Compared to NC-control mimics, over-expression of miR-192-5p
(i.e. miR-192-5pmimics) reduced luciferase activities by 3.3-fold (P=
0.0198) for the pMIR-SCN5A-3′UTR-T reporter gene (Fig. 1C). The
miR-192-5p mimics reduced the activity from pMIR-SCN5A-3′UTR-C
by 3.8-fold (P = 0.0346) (Fig. 1C). The data suggests that miR-192-5p
negatively regulates the activity of pMIR-SCN5A-3′UTR luciferase re-
porters containing themiR-192-5p target binding site.We also analyzed
the luciferase activity from a mutant pMIR-SCN5A-3′UTR-T reporter
genewith the putativemiR-192-5p target sequence (AGGTCAT) deleted
(pMIR-SCN5A-3′UTR-T-Mut). No signiﬁcance difference was found be-
tween miR-192-5p mimics and NC-control mimics. The data suggests
that miR-192-5p negatively regulates the activity of pMIR-SCN5A-3′
UTR luciferase reporters by targeting themiR-192-5p target binding se-
quence (AGGTCAT).
There was no statistical signiﬁcant difference between pMIR-
SCN5A-3′UTR-T and pMIR-SCN5A-3′UTR-C with or without miR-192-
5pmimics (P= 0.444 and 0.351, respectively) (Fig. 1B). The data sug-
gests that the T to C substitution (SNP rs41310757) at the miR-192-5p
binding site does not affect the expression SCN5A, consistent with the
ﬁnding that it is a benign polymorphism.
3.3. MiR-192-5p negatively regulates expression of SCN5A at both mRNA
and protein levels
To further validate theﬁnding thatmiR-192-5p regulates the expres-
sion of SCN5A, we assessed the expression level of SCN5AmRNA using
real-time qPCR analysis in SW620 cells with a relatively high expression
level of endogenous SCN5A. SW620 cells were transfected with miR-
192-5p mimics or NC-control miRNA mimics. Real-time qPCR analysis
showed that compared to control mimics, miR-192-5pmimics signiﬁ-
cantly reduced the level of SCN5A mRNA, although the magnitude of
reduction was only 17% (P= 0.0064) (Fig. 2A).
We then further examined the regulation of Nav1.5 encoded by
SCN5A at the protein level using Western blot analysis. Protein extracts
were isolated from SW620 cells transfected withmiR-192-5pmimics or
NC-control miRNA mimics. Western blotting analysis showed that
miR192-5p mimics signiﬁcantly reduced the expression level of
Fig. 2.MiR-192-5p negatively regulates expression of SCN5AmRNA or Nav1.5 protein. A.
MiR-192-5p overexpression with mimics signiﬁcantly reduced the expression level of
SCN5A mRNA in SW620 cells compared with negative control mimics (NC-control) by
real time qPCR analysis. GAPDHwas used as internal control and the fold change was cal-
culated by RQ values (2−ΔΔCt). B, C.MiR-192-5p overexpression with mimics signiﬁcantly
reduced the expression level of Nav1.5 protein in SW620 cells compared with negative
controlmimics (NC-control) byWestern blot analysis. GAPGHwasusedas loading control.
The images ofWestern blot analysis shown in (B) were scanned, quantiﬁed and plotted in
(C). The data was normalized to NC-miR. Data is shown as means ± SD.
Fig. 3. MiR-192-5p signiﬁcantly reduces the sodium current density. A. Representative
traces for sodium currents from HEK293 cells co-transfected with pcDNA3-SCN5A-
whole-3′UTR and negative control mimics (NC-control) (left) or miR-192-5p mimics
(right). The current protocol is depicted in the inset. B. Current–voltage (I–V) relation
for sodium currents. The average sodium current density is signiﬁcantly smaller in cells
transfected with miR-192-5pmimics than those transfected with NC-control mimics. C.
Histogram of sodium current densities at−20 mV. Data is in means ± SEM.
2029Y. Zhao et al. / Biochimica et Biophysica Acta 1852 (2015) 2024–2034Nav1.5 protein by 66% compared with the negative control mimics (P=
0.0023) (Fig. 2B and C).
Taken together, these results indicated thatmiR-192-5p signiﬁcantly
down-regulated the expression of cardiac sodium channel mRNA
(SCN5A) and protein (Nav1.5). The regulation is more on the protein
level than on themRNA level, 66% and 17%, respectively. These features
are consistent with the general regulatory characteristics by miRNAs.
3.4. MiR-192-5p reduces the density of cardiac sodium current
Nav1.5 is the sodium channel subunit that generates sodium current
in the heart. The sodium current is commonly analyzed by patch-
clamping of HEK293 cells transfected with the expression plasmid for
SCN5A. We co-transfected HEK293 cells with 2 μg of pcDNA3-SCN5A-
whole 3′UTR and 200 ng of pEGFP-N1 togetherwithmiR-192-5pmimics
or negative controlmiRNAmimics and selected cells with a green signal
for recordings of sodium current. Fig. 3A shows representative whole-
Fig. 4. Up-regulation ofmiR-192-5p expression in tissue samples from AF patients compared with non-AF controls by in situ hybridization. Representative images of in situ hybridization
are shown on the left. The images were scanned, quantiﬁed and plotted on the right. The data was normalized to non-AF control. Data is shown as means ± SD.
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plasmid expressing human SCN5A with its whole 3′UTR and pEGFP-N1
(marker for successful transfection) togetherwithmiRNAmimics. Com-
pared with NC-control miRNA mimics, cells expressing themiR-192-5p
mimics had amarkedly decreased sodium current density (peak current
normalized to cell capacitance, pA/pF, n = 19 cells/group) under test
potentials. As shown in Fig. 3C, compared with NC-control miRNA
mimics, miR-192-5p mimics signiﬁcantly reduced the sodium current
density recorded at −25 mV by 40% (−375.63 ± 59.14 pA/pF vs.
−224.21 ± 30.83 pA/pF). We also carried out Western blot analysis to
measure the expression level of Nav1.5. Consistent with electrophysio-
logical results,miR-192-5pmimics signiﬁcantly reduced the expression
level of Nav1.5 in transfected HEK293 cells (data not shown).
3.5. Correlation of increased miR-192-5p expression and down-regulation
of SCN5A/Nav1.5 in human AF tissue
A previous study with right atrial appendages from AF patients
showed that the expression level of the Nav1.5 protein and the peak so-
dium current density were reduced [11]. Therefore, we hypothesized
that the expression level of miR-192-5p, the negative regulator of
SCN5A, may be altered in AF. To test the hypothesis, we studied six left
appendage tissue samples, three of which were from AF patients and
threewere fromnormal non-AF controls (Table 1).We analyzed the ex-
pression of miR-192-5p using in situ hybridization with a miR-192-5p
anti-sense oligonucleotide probe. As shown in Fig. 4, miR-192-5p ex-
pression was signiﬁcantly up-regulated in AF samples compared with
non-AF control samples by 1.6-fold (P = 0.047). Consistent with up-
regulation ofmiR-192-5p, the expression level of Nav1.5was signiﬁcant-
ly down-regulated (P= 0.015) (Fig. 5). Therefore, there was a correla-
tion between up-regulation of miR-192-5p and down-regulation of
Nav1.5 in AF.
To conﬁrm the correlation between up-regulation of miR-192-5p
and down-regulation of Nav1.5 in AF, we studied another independent
set of AF samples and non-AF controls (left appendages) (Table 1) by
real-time qPCR analysis. As shown in Fig. 6A, miR-192-5p expression
was signiﬁcantly up-regulated in AF samples compared with non-AF
control samples by 3.9-fold (P= 0.020). The expression of SCN5A was
signiﬁcantly down-regulated in AF samples compared with control
samples by 3.3-fold (P = 0.028) (Fig. 6B). Together, the data suggests
that up-regulation of miR-192-5p is associated with down-regulation
of Nav1.5 in AF.
4. Discussion
Cardiac sodium channel gene SCN5A is critical to the generation of
cardiac action potentials and, when mutated, causes many cardiac ar-
rhythmias and sudden death. Therefore, the regulation of SCN5A expres-
sion and function must be in a delicate balance in cells and human
bodies. In this study, we report a novel post-transcriptional regulatory
mechanism for SCN5A expression and function. Our view of how target
genes are regulated has been dramatically altered by the important role
of miRNAs in the regulation of post-transcriptional protein expression.
In this study, we report thatmiR-192-5p is involved in the negative reg-
ulation of expression of both SCN5AmRNAandNav1.5 protein and in re-
ducing the density of peak sodium current generated by Nav1.5. Several
pieces of evidence strongly support the new ﬁnding. First, luciferase as-
says from Luc-SCN5A-3′-UTR reporter genes with themiR-192-5p bind-
ing site showed that miR-192-5p mimics signiﬁcantly decreased the
expression of SCN5A by 3.3-fold compared with negative control
miRNAmimics (Fig. 1C).When themiR-192-5p binding sitewas deleted
from the Luc-SCN5A-3′-UTR reporter, the effect of miR-192-5pmimics
was lost (Fig. 1C). Second, real time qPCR analysis and Western blot
analysis showed that miR-192-5p mimics signiﬁcantly reduced the
levels of both SCN5AmRNA andNav1.5 protein comparedwith negative
control miRNAmimics (Fig. 2A). Third,miR-192-5pmimics signiﬁcantlyreduced the sodium current density by about 40% compared with NC
control mimics (Fig. 3). Together, our study demonstrates an important
role of miRNAs in the posttranscriptional regulation of SCN5A.
Moreover, because SCN5A is a target for anti-arrhythmic therapies,
miR-192-5p becomes a target for anti-arrhythmic therapies.
Very little is known about the function of miR-192-5p. It was re-
ported that miR-192-5p was usually down-regulated in tumors [27,
40] and in patients with wet age-related macular degeneration
(plasma miRNA levels) [41]. In contrast, in this study we found that
miR-192-5p was signiﬁcantly up-regulated in tissue samples from
AF patients by both in situ hybridization and real-time qRT-PCR anal-
ysis (Figs. 4 and 6). Therefore, miR-192-5pmay play a role in several
different human diseases.
AF is the most common arrhythmia encountered at the clinical set-
ting and causes more than 15% of stroke cases. Reduced expression of
SCN5A/Nav1.5 and reduction of INa density have been reported in AF
[11]. In this study, we found that Nav1.5 expression was signiﬁcantly
down-regulated in AF left atrial appendage samples compared with
non-AF control samples by immunohistochemistry (Fig. 5). Similarly,
real-time qPCR analysis showed that the expression of SCN5A was also
signiﬁcantly down-regulated (Fig. 6B). Interestingly, the expression
level of miR-192-5p was signiﬁcantly up-regulated in AF samples
compared with non-AF controls (Figs. 4 and 6A). Considering our dem-
onstration that miR-192-5p directly down-regulates the expression of
SCN5A/Nav1.5, our data suggests that up-regulation of miR-192-5p
may be one of the causes for down-regulation of SCN5A/Nav1.5 in AF
tissue samples.
Reduction of INa density was reported not only in AF, but also in
heart failure and myocardial ischemia. The cardiac diseases with
reduced INa density may be potentially treated by modalities that
increase INa density or SCN5A expression. Our ﬁnding that SCN5A
is the ﬁrst downstream target of miR-192-5p in the heart makes it
an attractive target to modulate the expression of SCN5A and INa
density in diseased states. For example, inhibitors of miR-192-5p
may be used to increase SCN5A expression or enhance density of
INa, and treat patients with down-regulation of SCN5A or reduced
INa density as in AF, heart failure, myocardial ischemia, BrS and
other arrhythmias.
Houria et al. recently showed that miR-219 also regulated the ex-
pression of SCN5A, however, it increased the expression of both SCN5A
mRNA and Nav1.5 protein as well as INa in HL1 cells derived from
mouse atria [42]. MiRNAs normally down-regulates the expression of
its downstream target genes either by inducing mRNA degradation or
by inhibiting translation. Thus, it is surprising that miR-219 increases
the expression of SCN5A/Nav1.5, thus, the underlying mechanism
needs further clariﬁcation. On the contrary, here we show that miR-
192-5p down-regulates the expression of SCN5A/Nav1.5. Therefore, the
ﬁnding of regulation of SCN5A/Nav1.5 by miR-192-5p in this study dis-
tinguishes the regulation bymiR-219 into two aspects. First, as with al-
most all miRNAs,miR-192-5p down-regulates the expression of SCN5A/
Nav1.5 and INa. Second, themiR-192-5p binding sequences at the 3′-UTR
of SCN5A are not evolutionarily conserved in the elephant, rabbit, pig,
mouse, rat and other species (Fig. 1A). Therefore, regulation of SCN5A/
Nav1.5/INa by miR-192-5p may be speciﬁc for some species including
humans.
There is a limitation with the present study. The sample size for the
human AF study was small due to difﬁculties in collecting human tissue
samples. Future studies with larger sample sizes are needed to further
validate theﬁndingon the up-regulation ofmiR-192-5p in AF.Moreover,
the up-regulation ofmiR-192-5pmay be only onemechanism for the re-
duction of SCN5A expression and INa in AF. There may be other plausible
mechanisms for the reduction of INa. For example, Eleonora and Herren
showed that Ca2+/calmodulin-dependent kinase II (CaMKII) can also
regulate INa [43].
In conclusion, our results in this study demonstrate that the expres-
sion of cardiac sodium channel gene SCN5A and its function can be
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Fig. 6. Correlation between up-regulation ofmiR-192-5p expression and down-regulation
of SCN5A mRNA expression in tissue samples from AF patients compared with non-AF
controls by qRT-PCR analysis. A. Up-regulation ofmiR-192-5p expression in tissue samples
from three AF patients compared with three non-AF controls. B. Down-regulation of
SCN5A expression in tissue samples from three AF patients compared with three non-AF
controls. The data was normalized to non-AF control. Data is shown as means ± SD.
2033Y. Zhao et al. / Biochimica et Biophysica Acta 1852 (2015) 2024–2034regulated at the posttranscriptional level by miR-192-5p. Importantly,
we showed that the expression of miR-192-5p was up-regulated in AF
patients, which may promote the arrhythmia by down-regulating the
expression of SCN5A. This study provides important insights into the
posttranscriptional regulation of cardiac ion channels by miRNAs and
suggests that miR-192-5p may be an attractive target for novel
antiarrhythmia therapies for treating cardiac diseases with reduced
SCN5A expression and decreased INa density as in AF, heart failure, myo-
cardial ischemia, BrS and other arrhythmias.Author contributions
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